Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Journal of Cancer

• Publication date

  2010-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejca.2010.05.009PMID 20627535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy

  2010cited by this paper
• Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy

  2010cited by this paper
• A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?

  2009cited by this paper
• Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence

  2009cited by this paper
• Genetic prognostic and predictive markers in colorectal cancer

  2009cited by this paper
• Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.

  2009cited by this paper
• The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.

  2009cited by this paper
• Base Excision by Thymine DNA Glycosylase Mediates DNA-Directed Cytotoxicity of 5-Fluorouracil

  2009cited by this paper
• Microsatellite instability and DNA ploidy in colorectal cancer

  2009cited by this paper
• Clinical implications of microsatellite instability in sporadic colon cancers

  2009cited by this paper
• Deficient mismatch repair system in patients with sporadic advanced colorectal cancer

  2009cited by this paper
• Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression

  2009cited by this paper
• Genome-wide expression profile of sporadic gastric cancers with microsatellite instability.

  2009cited by this paper
• Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group

  2008cited by this paper
• Mutations in the RAS‐MAPK, PI(3)K (phosphatidylinositol‐3‐OH kinase) signaling network correlate with poor survival in a population‐based series of colon cancers

  2008cited by this paper
• Clinicopathological features of CpG island methylator phenotype‐positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation

  2008cited by this paper
• Ethnicity and Risk for Colorectal Cancers Showing Somatic BRAF V600E Mutation or CpG Island Methylator Phenotype

  2008cited by this paper
• Cohort study of fatty acid synthase expression and patient survival in colon cancer.

  2008cited by this paper
• CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

  2008cited by this paper
• Molecular classification and correlates in colorectal cancer.

  2008cited by this paper
• Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracilresponsive subgroup?

  2008cited by this paper
• Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer

  2008cited by this paper
• Association of family history with cancer recurrence and survival among patients with stage III colon cancer.

  2008cited by this paper
• Cost analysis of biomarker testing for mismatch repair deficiency in node‐positive colorectal cancer

  2008cited by this paper
• Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases.

  2008cited by this paper
• RHAMM, p21 Combined Phenotype Identifies Microsatellite Instability-High Colorectal Cancers with a Highly Adverse Prognosis

  2008cited by this paper
• Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.

  2007cited by this paper
• Reduced Likelihood of Metastases in Patients with Microsatellite-Unstable Colorectal Cancer

  2007cited by this paper
• Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study.

  2007cited by this paper
• Role of the BRAF Mutations in the Microsatellite Instability Genetic Pathway in Sporadic Colorectal Cancer

  2007cited by this paper
• Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer

  2007cited by this paper
• Molecular heterogeneity of colorectal cancer: Implications for cancer control.

  2007cited by this paper
• The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage

  2007cited by this paper
• 5-Fluorouracil is efficiently removed from DNA by the base excision and mismatch repair systems.

  2007cited by this paper
• Relationship between genetic alterations and prognosis in sporadic colorectal cancer

  2006cited by this paper
• Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer

  2006cited by this paper
• Genomic instability and colorectal cancer

  2006cited by this paper
• Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients.

  2006cited by this paper
• Microsatellite instability in colorectal cancer

  2006cited by this paper
• Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.

  2006cited by this paper
• The genetics of HNPCC: application to diagnosis and screening.

  2006cited by this paper
• Nuclear Maspin expression is associated with response to adjuvant 5‐fluorouracil based chemotherapy in patients with stage III colon cancer

  2006cited by this paper
• Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified

  2005cited by this paper
• Systematic review of microsatellite instability and colorectal cancer prognosis.

  2005cited by this paper
• Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.

  2005cited by this paper
• Significance of mutations in TGFBR2 and BAX in neoplastic progression and patient outcome in sporadic colorectal tumors with high-frequency microsatellite instability.

  2005cited by this paper
• Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers.

  2005cited by this paper
• Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer

  2005cited by this paper
• Microsatellite Instability and Colorectal Cancer Prognosis

  2005cited by this paper
• Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

  2005cited by this paper
• Clinical value of mitochondrial mutations in colorectal cancer.

  2005cited by this paper
• Prognostic and predictive relevance of microsatellite instability in colorectal cancer.

  2005cited by this paper
• Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability.

  2004cited by this paper
• Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

  2004cited by this paper
• Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival

  2004cited by this paper
• Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer.

  2004cited by this paper
• p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy.

  2004cited by this paper
• Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability.

  2003cited by this paper
• Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy.

  2003cited by this paper
• High‐frequency microsatellite instability predicts better chemosensitivity to high‐dose 5‐fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection

  2002cited by this paper
• Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis

  2002cited by this paper
• Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.

  2002cited by this paper
• Systematic review and meta‐analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma

  2002cited by this paper
• Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma.

  2002cited by this paper
• DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study.

  2002cited by this paper
• Prediction of the response of colorectal cancer to systemic therapy.

  2002cited by this paper
• Allelic loss of chromosome 2p21-16.3 is associated with reduced survival in sporadic colorectal cancer.

  2001cited by this paper
• Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.

  2001cited by this paper
• Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level.

  2001cited by this paper
• Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

  2001cited by this paper
• Sporadic colorectal adenocarcinomas with high‐frequency microsatellite instability

  2000cited by this paper
• Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy.

  2000cited by this paper
• p53 Gene Mutation, Microsatellite Instability and Adjuvant Chemotherapy: Impact on Survival of 388 Patients with Dukes’ C Colon Carcinoma

  2000cited by this paper
• Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.

  2000cited by this paper
• Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer

  2000cited by this paper
• Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.

  1999cited by this paper
• Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.

  1999cited by this paper
• Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer.

  1999cited by this paper
• A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

  1998cited by this paper
• In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.

  1997cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Statistical methods in cancer research: volume 1- The analysis of case-control studies

  1980cited by this paper
• The combination of estimates from different experiments.

  1954cited by this paper

• Adjuvant therapy in stage II-III colon cancer: 3 vs. 6 months, MSI-H, ctDNA integration

  2026cites this paper
• Clinical, Immunohistochemical, and Inflammatory Profiles in Colorectal Cancer: The Impact of MMR Deficiency

  2025cites this paper
• Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer

  2025cites this paper
• Predictive value of a mesenchymal phenotype grading system combining tumor budding and FRMD6 expression for disease-free survival in colorectal carcinomas.

  2025cites this paper
• Mismatch Repair Status and Associated Clinicopathological Factors Among Young-Onset Colorectal Carcinoma

  2025cites this paper
• Survival paradox and effect of adjuvant chemotherapy for high-risk Stage II and low-risk Stage III colorectal cancer

  2025cites this paper
• The Current Evidence and Future Direction of Adjuvant Treatment for Gastric Cancer in the Era of Precision Medicine

  2025cites this paper
• Validated nomograms for non-metastatic colorectal cancer prognosis prediction: a population-based study

  2025cites this paper
• Colorectal Cancer Risk Loci: Prognostic Factors for Clinical Outcomes? A Systematic Review and Meta‐Analysis

  2025cites this paper
• Sample size required for prognostic genes analysis in colorectal cancer

  2025cites this paper
• Integrating nutritional and inflammatory biomarkers in colorectal cancer management: Implications of microsatellite instability status

  2025cites this paper
• Prognostic Impact of Tumor Size in Patients with Stage T3N1 Colon Cancer

  2025cites this paper
• Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review)

  2024cites this paper
• Immunohistochemistry staining for DNA mismatch repair proteins in endoscopic biopsies and the corresponding surgical specimen in colorectal cancer.

  2024cites this paper
• Exploring prognostic values of DNA ploidy, stroma-tumor fraction and nucleotyping in stage II colon cancer patients

  2024influential citation
• Immunohistochemical Assessment of MLH1, MSH2, MSH6, and PMS2 Expression and Mismatch Repair Deficiency in Surgically Resected Colorectal Carcinomas

  2024cites this paper
• Current landscape of BRAF-V600E metastatic CRC management in Latin America: an expert Latin American panel’s recommendations

  2024cites this paper
• Systemic inflammatory response in colorectal cancer is associated with tumour mismatch repair and impaired survival

  2024cites this paper
• More subtle microsatellite instability better predicts fluorouracil insensitivity in colorectal cancer patients

  2024cites this paper
• Microsatellite Instability Testing and Prognostic Implications in Colorectal Cancer

  2024cites this paper
• Impact of perioperative prognostic nutritional index changes on the survival of patients with stage II/III colorectal cancer

  2024cites this paper
• Research advances in the molecular classification of gastric cancer

  2024cites this paper
• Correlation between mismatch repair statuses and the prognosis of stage I–IV colorectal cancer

  2024cites this paper
• Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.

  2024cites this paper
• From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies

  2024cites this paper
• Association of High Body Mass Index in Early Life With the Development of Colorectal Cancer

  2024cites this paper
• A Standardized Pathology Report for Gastric Cancer: 2nd Edition

  2023cites this paper
• A recurrence‐predictive model based on eight genes and tumor mutational burden/microsatellite instability status in Stage II/III colorectal cancer

  2023influential citation
• Dysregulated of the FAM138E and CLRN1-AS1 lncRNAs could be diagnosis biomarkers in colorectal cancer

  2023cites this paper
• Spectrum of Colorectal Adenocarcinomas: A 4 year experience in a tertiary care centre from Western Maharashtra

  2023cites this paper
• Pilot radiogenomic evaluation of colorectal cancer - Are there preoperative radiological features of the dMMR phenotype?

  2023cites this paper
• Chemokine- and chemokine receptor-based signature predicts immunotherapy response in female colorectal adenocarcinoma patients

  2023cites this paper
• A nomogram was developed using clinicopathological features to predict postoperative liver metastasis in patients with colorectal cancer

  2023cites this paper
• Prognostic value of primary tumor location in colorectal cancer: an updated meta-analysis

  2023cites this paper
• Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair Status

  2023cites this paper
• Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers

  2023cites this paper
• The prognostic significance of microsatellite instability in colorectal cancer: a Swedish multi-center study

  2023cites this paper
• Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer.

  2023cites this paper
• Molecular subtyping in colorectal cancer: A bridge to personalized therapy (Review).

  2023cites this paper
• Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice

  2023cites this paper
• A standardized pathology report for gastric cancer: 2nd edition

  2023cites this paper
• Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer

  2023cites this paper
• Neoadjuvant immunotherapy in colorectal cancer beyond immune checkpoint inhibitors: emerging from bench to bedside.

  2023cites this paper
• Tissue-resident memory T cells in gastrointestinal tumors: turning immune desert into immune oasis

  2023cites this paper
• Development of Tissue-Agnostic Treatments for Patients with Cancer

  2022cites this paper
• Association of microsatellite instability (MSI) status with the 5-year outcome and genetic ancestry in a large Brazilian cohort of colorectal cancer

  2022cites this paper
• Impact of microsatellite status in early-onset colonic cancer.

  2022cites this paper
• Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma

  2022cites this paper
• The Emerging Role of Tissue-Resident Memory CD8+ T Lymphocytes in Human Digestive Tract Cancers

  2022cites this paper
• Current Perspectives on the Importance of Pathological Features in Prognostication and Guidance of Adjuvant Chemotherapy in Colon Cancer

  2022cites this paper
• Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3‐4 colon cancer

  2022cites this paper
• Body mass index and molecular subtypes of colorectal cancer

  2022cites this paper
• Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature

  2022cites this paper
• Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients

  2022cites this paper
• Clinical Significance of Fusobacterium nucleatum and Microsatellite Instability in Evaluating Colorectal Cancer Prognosis

  2022cites this paper
• Clinical Significance of Fusobacterium nucleatum and Microsatellite Instability in Evaluating Colorectal Cancer Prognosis

  2022cites this paper
• Analysing 11 years of incidence trends, clinicopathological characteristics, and forecasts of colorectal cancer in young and old patients: a retrospective cross-sectional study in an Indonesian national referral hospital

  2022cites this paper
• Survival outcomes associated with Lynch syndrome colorectal cancer and metachronous rate after subtotal/total versus segmental colectomy: Meta-analysis.

  2022cites this paper
• Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study

  2022cites this paper
• PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients

  2022cites this paper
• epialleleR: an R/Bioconductor package for sensitive allele-specific methylation analysis in NGS data

  2022cites this paper
• Associations of cigarette smoking, alcohol drinking and body mass index with survival after colorectal cancer diagnosis by anatomic subsite: a prospective patient cohort study in Japan.

  2022cites this paper
• Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods

  2022cites this paper
• Identification of a 3-gene signature for predicting the prognosis of stage II colon cancer based on microsatellite status.

  2021cites this paper
• A chemoresistance lncRNA signature for recurrence risk stratification of colon cancer patients with chemotherapy

  2021cites this paper
• Systematic review and meta-analysis of tumour microsatellite-instability status as a predictor of response to fluorouracil-based adjuvant chemotherapy in colorectal cancer

  2021cites this paper
• Pathological Features and Prognostication in Colorectal Cancer

  2021cites this paper
• Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction

  2021cites this paper
• Morphology Matters

  2021cites this paper
• Genome profiling of mismatch repair genes in eight types of tumors

  2021cites this paper
• A Simple, Accurate and Cost-Effective Capillary Electrophoresis Test with Computational Methods to Aid in Universal Microsatellite Instability Testing

  2021cites this paper
• Microsatellite Instability as a Predictor of Outcomes in Colorectal Cancer in the Era of Immune-Checkpoint Inhibitors.

  2021cites this paper
• Microsatellite Instability in Sporadic Colorectal Malignancy: A Pilot Study from Northern India

  2021cites this paper
• Assessment of the Circulating Tumor Cells and Microsatellite Instability in Colorectal Cancer Patients: Prognostic and Diagnostic Value

  2021cites this paper
• Microsatellite Instability in Colorectal Cancer Liquid Biopsy—Current Updates on Its Potential in Non-Invasive Detection, Prognosis and as a Predictive Marker

  2021cites this paper
• Assessment of mismatch repair deficiency, CDX2, beta-catenin and E-cadherin expression in colon cancer: molecular characteristics and impact on prognosis and survival – an immunohistochemical study

  2021cites this paper
• Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers

  2021cites this paper
• Neoadjuvante Immuntherapie beim Kolonfrühkarzinom

  2021cites this paper
• Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis

  2021cites this paper
• A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment

  2021cites this paper
• Expression of Thomsen–Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability

  2021cites this paper
• Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy.

  2021cites this paper
• The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy

  2021cites this paper
• Cytotoxic CD8+ T cells and tissue resident memory cells in colorectal cancer based on microsatellite instability and BRAF status

  2021cites this paper
• Biomarkers as Putative Therapeutic Targets in Colorectal Cancer

  2021cites this paper
• Pembrolizumab in unresectable or metastatic MSI-high colorectal cancer: safety and efficacy

  2020cites this paper
• A comparative prognostic performance of definitions of Crohn-like lymphoid reaction in colorectal carcinoma

  2020cites this paper
• The clinical utility of microsatellite instability in colorectal cancer.

  2020cites this paper
• Implication of Microsatellite Instability in Chinese Cohort of Human Cancers

  2020cites this paper
• Colorectal Cancer Genetics: An Overview of the Actionable Building Blocks

  2020cites this paper
• Immuno-Interface Score to Predict Outcome in Colorectal Cancer Independent of Microsatellite Instability Status

  2020cites this paper
• Frequency and coexistence of KRAS, NRAS, BRAF and PIK3CA mutations and occurrence of MMR deficiency in Danish colorectal cancer patients

  2020cites this paper
• Molecular Insights Into Colorectal Carcinoma.

  2020cites this paper
• Clinical implications of mismatch repair deficiency screening in patients with mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN).

  2020cites this paper
• Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing: A Big Chapter in the Tale

  2020cites this paper
• CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study

  2020cites this paper
• Prognostic Value and Immunohistochemical Analysis of Mismatch Repair Deficiency in Patients with Stage II and III Colorectal Carcinoma—A Single-Center Study

  2020cites this paper
• Current status on microsatellite instability, prognosis and adjuvant therapy in colon cancer: A nationwide survey of medical oncologists, colorectal surgeons and gastrointestinal pathologists

  2020cites this paper
• Predictive molecular markers in the era of immunotherapy

  2020cites this paper
• The IL-33/ST2 pathway suppresses murine colon cancer growth and metastasis by upregulating CD40 L signaling.

  2020cites this paper